Neumora Therapeutics, Inc. Common Stock

NASDAQ:NMRA

Biotechnology

Healthcare
$0.37 -6.21%

-$0.10 today

Market cap
$69.21M
Beta
2.76
P/E (TTM)
-1.2
EPS (TTM)
-$1.24
52W Low $0.72High $3.65

Volume 1.50M

Average 2.02M

Balance Sheet

Inspect the capital base behind the business.

Assets

$191.05M

FY 2025 · Annual

-39.7% YoY

Liabilities

$87.18M

FY 2025 · Annual

+191.5% YoY

Equity

$103.87M

FY 2025 · Annual

-63.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents409.25M240.94M374.04M142.15M182.53M
Short-term Investments0130.94M79.94M165.43M0
Net Receivables200K919K939K00
Inventory00000
Other Current Assets125K50K06.48M8.01M
Total Current Assets415.6M387.96M478.28M314.06M190.54M
Property, Plant & Equipment (Net)4.04M10.64M6.86M2.92M457K
Goodwill00000
Intangible Assets00000
Long-term Investments023.51M9.85M00
Tax Assets00000
Other Non-current Assets9.65M4.13M1.21M053K
Total Non-current Assets13.69M38.28M17.92M2.92M510K
Total Assets429.3M426.23M496.2M316.97M191.05M
Account Payables1.64M7.15M337K3.31M3.38M
Short-term Debt0000284K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities8.13M10.04M10.15M10.11M28.79M
Total Current Liabilities23.28M23.7M25.11M29.89M32.45M
Long-term Debt0000193K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities730.24M844.32M155K22K54.53M
Total Non-current Liabilities731.24M849.39M2.01M22K54.73M
Total Liabilities754.52M873.08M27.12M29.91M87.18M
Common Stock3K3K16K16K17K
Retained Earnings(336.61M)(467.51M)(703.43M)(947.22M)(1.18B)
Accumulated OCI0(774K)(76K)62K0
Other Stockholders Equity00000
Minority Interest00000
Total Equity(325.22M)(446.85M)469.08M287.06M103.87M
Total Debt2.05M8.44M5.23M1.85M477K
Net Debt(407.2M)(232.5M)(368.81M)(140.3M)(182.05M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$147.1M
Other Current$6.4M
Total Current Assets$153.4M
PP&E (Net)$390.0K
Other Non-current$53.0K
Total Non-current Assets$443.0K
Total Assets$153.9M

Analysis

Selected assets total $153.9M for Latest. The largest visible component is Cash & Equivalents at $147.1M, about 95.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 30, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
4Statement of changes in beneficial ownershipAug 21, 2026

How much cash does NMRA have?

Neumora Therapeutics, Inc. Common Stock (NMRA) reported $182.53M in cash and equivalents in fiscal 2025.

How much debt does NMRA carry?

Neumora Therapeutics, Inc. Common Stock (NMRA) reported $477,000.00 of total debt, with net debt of -$182.05M.